Apply to trial NCT07738107

A few quick questions so the study team can decide if you might be a fit.

RecruitingDrug trial

ATR 1072 in Participants With PRKAG2 Syndrome

ATR 1072 is an investigational medicine being studied in adults with PRKAG2 Syndrome. This study will evaluate the safety of ATR 1072 and how the body processes the drug. Researchers will also assess how ATR 1072 affects PRKAG2 activity and measures of heart disease.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

ATR 1072 in Participants With PRKAG2 Syndrome

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening